You are here: Industry Insights > 10X Genomics

News List

10x Genomics Signs Patent Agreement with Bio-Rad americanpharmaceuticalreview
July 28, 2021
10x Genomics Inc. announced that it has entered into a global settlement and cross-license agreement with Bio-Rad Laboratories Inc..
10x Genomics Launches Immune Profiling Product to Combat COVID-19 americanpharmaceuticalreview
July 23, 2020
10x Genomics has launched its Chromium Single Cell Immune Profiling v2 product. The new product extends the capabilities of the original version, supporting breakthroughs in immunology, oncology, autoimmunity, inflammation, transplant biology, and ...
Merck and 10x Genomics launch new option for CRISPR research expresspharma
June 12, 2020
The companies will work together as part of 10x Genomics’ 10x Compatible Partnership Program, a global ecosystem of technologies and solutions that provide customers with the ability to enhance their unique research applications and accelerate discovery.
10x Genomics Launches Targeted Gene Expression Solution americanpharmaceuticalreview
May 27, 2020
10x Genomics has launched its Targeted Gene Expression Solution for single cell and shortly following for spatial genomic research.
10x Genomics Becomes First One Medical Customer to Deploy Cohort-Based COVID-19 Employee Testing americanpharmaceuticalreview
May 21, 2020
10x Genomics and One Medical announced the two organizations are partnering to develop a path toward the safe return to work by deploying a comprehensive approach to COVID-19 testing, digital employee symptom screening ...
10x Genomics steps into tissue-level gene expression mapping with Spatial Transcriptomics acquisition fiercebiotech
December 28, 2018
10x Genomics is making moves into the emerging field of spatial genomics—which looks to map out the interworking of cells within the context of larger tissues—by buying Spatial Transcriptomics and its tools for high-throughput mRNA analysis.....
10x Genomics acquires epigenetic startup Epinomics in first M&A fiercebiotech
September 03, 2018
Epinomics was founded by the developers of ATAC-seq technology, for profiling the compounds and proteins that attach to DNA and turn specific genes on or off. (kirstypargeter/iStock/Getty Images Plus)